Edwards Lifesciences Corp

NYSE:EW   3:59:57 PM EDT
101.99
-6.64 (-6.11%)
4:00:00 PM EDT: $101.88 -0.11 (-0.11%)
Other Pre-Announcement

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference

Published: 12/08/2021 14:25 GMT
Edwards Lifesciences Corp (EW) - Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference.
Reaffirming October 2021 Financial Guidance.
Projecting 2022 Global Sales of $5.5 - $6.0 Billion; Underlying Growth in Low Double-digits.
Projecting 2022 Tavr Sales of $3.7 - $4.0 Billion; Underlying Growth 12-15%.
Projecting 2022 Tmtt Sales of $140 - $170 Million.
Estimating 2022 Adjusted Earnings per Share $2.50 - $2.65.
Focused Long-term Growth Investments With 2022 Research and Development Planned at 17-18% of Sales.
FY2022 Earnings per Share View $2.58, Revenue View $5.85 Billion -- Refinitiv Ibes Data (analyst estimates).